Wednesday wallop:
Lernahooligan alert: Lernout & Hauspie (LHSP), since you didn't ask, reported first-quarter earnings last night. Looked like a blowout, with earnings coming in at 19 cents per share vs. estimates of 15 cents. (So what if the estimates had been reduced in February, at the company's direction, from 22 cents.) Receivables days outstanding leaped to 105 days from 86 days on flat sales from the prior quarter, suggesting (so say short-sellers) an overstuffed distribution channel. Receivables, in fact, rose by $24 million (or just shy of one-quarter of the entire quarter's revenue). Without the increase, "earnings would've been 3 cents per share," one short says. Oh, and biz with Microsoft (MSFT), supposedly Lernout's great partner, was down from the prior quarter to $7.3 million from $8.5 million. (You get that by comparing what the company disclosed in its year-end press release with what it disclosed on its conference call.) That's what happens, you could argue, when a big customer/partner becomes a big competitor. Sales for the whole company, meanwhile, were flat sequentially, despite acquisitions that should've added revenue. Doesn't say much for the company's core biz. And for that investors are paying 100 times expected earnings?! Yep. Prescription pitfalls: An item in yesterday's Herb's Hotline (check it out!) mentioned that even though CVS (CVS), the drugstore chain, met analysts' estimates for the first quarter, some skeptics (read it: short-sellers) thought the quarter was a farce. A farce? That may have been an overstatement, but the point was this: "Anybody who looks below the surface sees inconsistencies," says one longtime CVS bear. One of the most glaring was that at the end of last quarter, the company said it had a better handle on inventories and free cash flow (operating cash flow minus capital expenditures). It also had warned investors to expect seasonally low cash flow from operations in the first quarter.TheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,801.23 | 1,342.64 | 2,903.88 | 19.69 |
Oil *
117.67
|
|
DOWN
89.23 |
DOWN
9.31 |
DOWN
23.35 |
DOWN
0.78 |
10 Yr
1.97%
SPDR Gold
167.14
|
|
-0.69%
|
-0.69%
|
-0.80%
|
-3.81%
|
Data delayed 20 minutes |

Connect with TheStreet